688221 前沿生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-4.237-21.828-20.377-13.090-16.810
总资产报酬率 ROA (%)-2.638-14.457-14.434-10.301-13.353
投入资产回报率 ROIC (%)-2.871-15.867-15.742-11.050-9.704

边际利润分析
销售毛利率 (%)31.08928.99518.605-30.43818.419
营业利润率 (%)-225.314-286.857-421.616-660.429-504.985
息税前利润/营业总收入 (%)-225.666-281.255-421.061-667.212-506.338
净利润/营业总收入 (%)-226.006-287.935-421.008-654.939-505.154

收益指标分析
经营活动净收益/利润总额(%)111.389106.828111.148119.975102.003
价值变动净收益/利润总额(%)-8.192-5.065-5.590-14.330-2.419
营业外收支净额/利润总额(%)0.3060.374-0.144-0.8380.033

偿债能力分析
流动比率 (X)3.0152.9015.0723.94916.397
速动比率 (X)2.8552.7464.8713.85216.277
资产负债率 (%)38.23137.26230.67027.73414.929
带息债务/全部投入资本 (%)14.56314.0507.5879.575--
股东权益/带息债务 (%)461.362486.4361,009.651813.142-5,712.080
股东权益/负债合计 (%)161.565168.373226.052260.565570.460
利息保障倍数 (X)-663.838-42.1077,917.32554.367427.673

营运能力分析
应收账款周转天数 (天)201.758156.202124.219240.9220.000
存货周转天数 (天)303.161254.308245.900177.6690.000